Results · Apr-Jun 2026
Symbiox Investment & Trading Co. Q1 FY27 results
Sales fell 44% to ₹0.26 crore from ₹0.46 crore in Apr-Jun 2025.
Operating profit grew 18% to ₹0.11 crore, an operating margin of 41.2% (up 21.7 points from a year ago).
Net profit grew 16% to ₹0.08 crore from ₹0.07 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −69%, net profit +534%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.3 | 0.5 | −44% |
| Operating profit (EBITDA) | 0.1 | 0.1 | +18% |
| Operating margin | 41.2% | 19.5% | +21.7 pts |
| Net profit | 0.1 | 0.1 | +16% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.